Dr Reddys launches OTC store-brand equivalent of Allegra-D? 24 HR in US market

22 Jul 2022 , 03:09 PM

Dr. Reddys Laboratories announced the first-to-market launch of over-the-counter (OTC) Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets, USP, the store-brand equivalent of Allegra-D? 24 HR in the U.S. market, as approved by the U.S. Food and Drug Administration (USFDA). Dr. Reddys OTC Fexofenadine HCl 180 mg and Pseudoephedrine HCl 240 mg Extended Release Tablets, USP is an over-the-counter oral antihistamine and nasal decongestant for the temporary relief of nasal and sinus congestion due to colds or allergies. It temporarily relieves sneezing; runny nose; itchy, watery eyes; and itchy nose or throat due to allergies. Allegra-D? 24 HR had U.S. retail sales of approximately $45 million as of May 2022 according to IRI. Powered by Capital Market – Live News